RXII

GALENA BIOPHARMA INC COM
RXII

Overview Fund Activity
Delisted

RXII was delisted on the 25th of October, 2011.

Back to rankings

79 hedge funds and large institutions have $33.3M invested in GALENA BIOPHARMA INC COM in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 16 closing their positions.

Holders
79
Holders Change
-6
Holders Change %
-7.06%
% of All Funds
2.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
20
Reduced
23
Closed
16
Calls
$3.07M
Puts
$3.87M
Net Calls
-$801K
Net Calls Change
-$1.66M

Top Buyers

1
BFA
1
BlackRock Fund Advisors
California
$4.93M
2
SIM
2
Spark Investment Management
New York
$462K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$6.05M
4
Millennium Management
4
Millennium Management
New York
$362K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$1.36M

Top Sellers

1
SGAM
1
Smith Group Asset Management
Texas
$0
2
HCA
2
Harbour Capital Advisors
Virginia
$0
3
MLICM
3
Metropolitan Life Insurance Company (MetLife)
New York
$0
4
TNB
4
Thomasville National Bank
Georgia
$0
5
BNP Paribas Financial Markets
5
BNP Paribas Financial Markets
France
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PA
101
Perceptive Advisors
New York
– – – –
Royal Bank of Canada
102
Royal Bank of Canada
Ontario, Canada
$0 49 +49 New
1 2 3 4
5